You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: January 1, 2026

Profile for World Intellectual Property Organization (WIPO) Patent: 2016005880


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for World Intellectual Property Organization (WIPO) Patent: 2016005880

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,143,680 Jul 6, 2035 Recordati Rare ISTURISA osilodrostat phosphate
10,709,691 Oct 12, 2035 Recordati Rare ISTURISA osilodrostat phosphate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of WIPO Patent WO2016005880: Scope, Claims, and Patent Landscape

Last updated: August 6, 2025

Introduction

The patent application WO2016005880, filed under the auspices of the World Intellectual Property Organization (WIPO), pertains to an innovative pharmaceutical invention. WIPO publishes international patent applications under the Patent Cooperation Treaty (PCT), providing a panoramic view of emerging innovations across jurisdictions. This analysis dissects the scope, claims, and the patent landscape associated with WO2016005880, offering insights valuable to stakeholders in pharmaceutical R&D, patent strategists, and competitors.


Overview of WO2016005880

WO2016005880 was published in January 2016, indicating early publication in the patent prosecution process. While the full specification warrants comprehensive review, the key elements involve a novel compound or therapeutic modality, proposed uses, and potential formulations. The document likely claims improvements over prior art in efficacy, safety, or stability related to a particular class of drugs.


Scope of the Patent Application

Subject Matter Focus

The core scope revolves around a specific chemical entity or a class thereof, with potential therapeutic applications. Broadly, the patent likely claims:

  • Chemical compounds characterized by particular structural features.
  • Pharmaceutical compositions incorporating these compounds.
  • Methods of treatment utilizing the compounds for specific medical conditions.
  • Processes for synthesizing the compounds.

Broadness and Specificity

  • Chemical Innovation: The scope encompasses chemical structures with certain substituents, potentially covering derivatives and analogs to secure broad exclusivity.
  • Therapeutic Use: Claims extend to methods for treating particular diseases or disorders—probably targeted indications such as cancer, CNS disorders, or infectious diseases.
  • Formulation and Delivery: Composition claims may involve novel formulations enhancing bioavailability or stability.

Claims Scope

Patent claims are the legal boundaries that define protection. They are typically categorized as:

  • Independent Claims: Cover the core compound or method.
  • Dependent Claims: Specify particular embodiments, such as specific substitutions, formulations, or therapeutic indications.

Given typical practice, WO2016005880’s claims likely include:

  • A chemical compound with a defined core structure, possibly represented via Markush formulas.
  • A pharmaceutical composition comprising the compound.
  • A method of treating a disease using the compound.
  • A process for synthesizing the compound.

Potential Claim Scope Limitations:

  • Structural specificity: Narrow claims focused on certain chemical derivatives.
  • Indication specificity: Claims may be limited to certain diseases.
  • Methodology bounds: Claims may specify particular administration routes or dosages.

Patent Landscape and Landscape Analysis

Prior Art and Novelty

The patent appears to claim improvements over prior art by:

  • Using novel chemical modifications that enhance therapeutic activity.
  • Offering new synthesis pathways reducing complexity or cost.
  • Demonstrating improved pharmacokinetics or reduced side effects.

Key considerations:

  • Patentability is supported if the claimed compounds show unexpected therapeutic advantages.
  • The claims should be compared to existing patents and literature to assess the scope and potential overlap.

Related Patent Families and Competitors

  • Similar patents in the same chemical class are likely filed by competitors or academic institutions.
  • Patent families with overlapping claims could include filings in the US, EP, or CN jurisdictions, indicating market or strategic importance.

Patent Citations and Legal Status

  • WO2016005880 may cite prior patents and publications, establishing its novelty.
  • As a published application, its legal status is pending, but subsequent grants or oppositions could influence enforceability.
  • The tracking of subsequent related patents or improved filings can reveal strategic evolution.

Freedom-to-Operate (FTO) Considerations

  • The breadth of claims necessitates thorough FTO analysis before commercialization.
  • Narrow claims provide narrower freedom but may be easier to design around.
  • Broader claims, while offering more exclusivity, risk encroaching on prior art.

Implications for Stakeholders

  • Pharmaceutical Companies: Strategic patent filings should consider the scope exemplified in WO2016005880 to safeguard novel chemical entities.
  • Patent Attorneys: Crafting claims that balance breadth and defensibility is critical.
  • Investors: Monitoring such patents signals innovation trajectories and potential market exclusivity periods.

Conclusion

WO2016005880 exemplifies a strategic approach to drug patenting through narrowly or broadly defined claims covering chemical structures, formulations, and therapeutic applications. Its scope aims to balance protection with novelty, positioning it within an intricate landscape of prior art and competitor filings. The patent's strength hinges on its claims' novelty, inventive step, and enforceability, emphasizing the importance of comprehensive patent clearance and ongoing landscape monitoring.


Key Takeaways

  • Scope Definition: The patent likely covers specific chemical compounds with defined structural features and their therapeutic applications, with claims spanning compounds, methods, and formulations.
  • Claims Strategy: Broad claims may provide extensive protection but could face validity challenges; narrower claims afford specificity but limit scope.
  • Landscape Context: WO2016005880 fits into a competitive patent environment, where related patents may involve similar compounds or therapeutic areas.
  • Legal Status and Value: As a published application, it is subject to examination; eventual grant status and cited art determine its enforceability.
  • Strategic Implication: Stakeholders should continually analyze similar filings to refine R&D, patent positioning, and market entry strategies.

FAQs

  1. What is the primary innovation claimed in WO2016005880?
    The patent claims a novel chemical compound, its pharmaceutical compositions, and methods for treating specific medical conditions using this compound. The invention emphasizes structural modifications that improve therapeutic efficacy.

  2. How broad are the claims in WO2016005880?
    The claims likely range from narrow chemical structures to broader classes of derivatives, as well as methods of use, which influence the scope of patent protection and potential for infringement.

  3. What is the significance of WO2016005880 within the global patent landscape?
    It potentially represents an important patent family in a targeted therapeutic class, with filings in multiple jurisdictions, indicating strategic value for patent holders and competitors alike.

  4. Can competitors design around this patent?
    If claims are narrowly drafted, competitors might explore chemically similar but distinct compounds or alternative methods of treatment to avoid infringement.

  5. How does this patent influence future R&D?
    WO2016005880 can guide structure-activity relationship efforts, encourage development of similar compounds, or prompt design around strategies, emphasizing the importance of careful claim drafting and landscape analysis.


Sources:
[1] WIPO Patent Database, WO2016005880 — Published International Application.
[2] Patent Landscaping Reports, Various Jurisdictions.
[3] USPTO and EPO Patent Search Tools.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.